Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole
- 1 August 2014
- journal article
- Published by Elsevier in Life Sciences
- Vol. 110 (1) , 35-43
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Microcapsules of alginate/chitosan containing magnetic nanoparticles for controlled release of insulinColloids and Surfaces B: Biointerfaces, 2010
- Effect of the preparation method on the drug loading of alginate-chitosan microspheresExpress Polymer Letters, 2010
- Influence of the composition and preparation method on the morphology and swelling behavior of alginate–chitosan hydrogelsCarbohydrate Polymers, 2008
- Endoscopic Analysis of Gastric Ulcer after One Week's Treatment with Omeprazole and Rabeprazole in Relation to CYP2C19 GenotypeDigestive Diseases and Sciences, 2007
- Hydrophilic matrices: Application of Placket–Burman screening design to model the effect of POLYOX–carbopol blends on drug releaseInternational Journal of Pharmaceutics, 2006
- Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applicationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Modeling and comparison of dissolution profilesEuropean Journal of Pharmaceutical Sciences, 2001
- CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazoleAlimentary Pharmacology & Therapeutics, 2000
- Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kineticsInternational Journal of Pharmaceutics, 1999
- Investigation of Factors Influencing Release of Solid Drug Dispersed in Inert Matrices IIIJournal of Pharmaceutical Sciences, 1966